La galectina-3, una nueva diana terapéutica para las alteraciones cardiovasculares asociadas al desarrollo de la estenosis aórtica severa

Aortic stenosis is one of the most common heart valve diseases, as well as one of the most common causes of heart failure in the elderly. Currently, there are no medical therapies to prevent or slow the progression of the disease. When symptoms develop alongside severe aortic stenosis, there is a po...

Descripción completa

Detalles Bibliográficos
Autores: Arrieta, V. (V.)|||/items/f31f3a08-ccce-4ada-8659-459de975e7a3, Sádaba, J.R. (J. Rafael)|||/items/ad853803-330f-4ed2-8976-9f567c3ebc42, Álvarez, V. (V.)|||/items/abd2ffc1-dbe9-41ab-961a-bee8d476be17, Rodriguez, J.A. (José Antonio)|||/items/dfeeb791-bd5d-4472-bce8-b7f54cdf8f31, Lopez-Andres, N. (Natalia)|||/items/80a86f6a-0bfc-4fa8-af4a-e6c1bd49e0be
Tipo de recurso: artículo
Fecha de publicación:2019
País:España
Institución:Universidad de Navarra
Repositorio:Dadun. Depósito Académico Digital de la Universidad de Navarra
Idioma:español
OAI Identifier:oai:dadun.unav.edu:10171/64975
Acceso en línea:https://hdl.handle.net/10171/64975
Access Level:acceso abierto
Palabra clave:Galectin-3
Aortic stenosis
Myocardial fibrosis
Valve calcification
Galectina-3
Estenosis aórtica
Fibrosis miocárdica
Calcificación valvular
Descripción
Sumario:Aortic stenosis is one of the most common heart valve diseases, as well as one of the most common causes of heart failure in the elderly. Currently, there are no medical therapies to prevent or slow the progression of the disease. When symptoms develop alongside severe aortic stenosis, there is a poor prognosis unless aortic valve replacement is performed. Aortic stenosis is a heterogeneous disease with a complex pathophysiology involving structural and biological changes of the valve, as well as adaptive and maladaptive compensatory changes in the myocardium and vasculature in response to chronic pressure overload. Galectin-3 serves important functions in numerous biological activities including cell growth, apoptosis, differentiation, inflammation and fibrosis. With evidence emerging to support the function of Galectin-3, the current review aims to summarize the latest literature regarding the potential of Galectin-3 as therapeutic target in aortic valve and cardiovascular alterations associated with aortic stenosis.